Shionogi, Inc.

Colin E Rowlings

Beth A Burnside

Henry H Flanner

Sandra E Wassink

Donald J Treacy, Jr

Bruce X Cao

John A Bonck

An antibiotic product is comprised of at least three dosages forms, each of which has a different release profile, with the Cfor the antibiotic product being reached in less than about twelve hours after the initial release of antibiotic. In one embodiment, there is a delayed release dosage form, as well as two or more delayed sustained release dosage forms, with each of the dosage forms having a different release profile, wherein each reaches a Cat different times.

Antibiotic product, use and formulation thereof

A pharmaceutical tablet comprising an immediate release portion containing an active ingredient and a delayed release portion, wherein the delayed release portion comprises an enteric-coated layer and within the enteric-coated layer there is at least one member selected from the group consisting of enteric-coated microparticle dosage forms containing an active ingredient and enteric-coated mini-tablet dosage forms containing an active ingredient, is disclosed.

Tablet for pulsed delivery

An antibiotic product is comprised of at least three dosage forms, each of which has a different release profile, with the Cfor the antibiotic product being reached in less than about twelve hours after the initial release of antibiotic. In one embodiment, there are two delayed release dosage forms, as well as a delayed sustained release dosage form, with each of the dosage forms having a different release profile, wherein each reaches a Cat different times.

An antibiotic product is comprised of at least three dosages forms, each of which has a different release profile, with the Cfor the antibiotic product being reached in less than about twelve hours. In one embodiment, there is an immediate release dosage form, as well as two or more sustained release dosage forms, with each of the dosage forms having a different release profile, wherein each reaches a Cat different times.

An antibiotic product is comprised of at least three dosages forms, each of which has a different release profile, with the Cfor the antibiotic product being reached in less than about twelve hours. In one embodiment, there is an immediate release dosage form, a sustained release dosage form, and a delayed release dosage form, with each of the dosage forms having a different release profile, wherein each reaches a Cat different times.

An antibiotic product is comprised of at least three dosages forms, each of which has a different release profile, with the Cfor the antibiotic product being reached in less than about twelve hours. In one embodiment, there is an immediate release dosage form, a delayed release dosage form, and a sustained release dosage form, with each of the dosage forms having a different release profile, wherein each reaches a Cat different times.

Growing community of inventors

Potomac, IN, United States of America

Colin E Rowlings